Sarcoma medical oncologist Laurence H. Baker, DO (@LaurenceBaker2), will answer your questions on drug development during a 45-minute tweet chat on Thursday, September 24, at 9 pm (EST).
Dr. Baker is a professor of internal medicine and pharmacology at the University of Michigan Medical School in Ann Arbor. He has served as director for clinical research and hematology/oncology at UM’s Comprehensive Cancer Center; chairman of the Southwest Oncology Group, the largest clinical trials organization in the United States; executive director of the Sarcoma Alliance for Research through Collaboration, a national cooperative group that runs sarcoma clinical trials; and president of the Connective Tissue Oncology Society, an international group of sarcoma physicians and scientists. Dr. Baker has treated sarcoma patients for more than 40 years, but instead of retiring, he helped establish UM’s sarcoma survivorship clinic last year.
The tweet chat co-hosts will be:
- Bert E. Thomas IV, PhD, MBA (@SFA_Bert), CEO of the Sarcoma Foundation of America in Damascus, MD.
- Corrie Painter, PhD (@Corrie_Painter), an angiosarcoma survivor, is vice president of Angiosarcoma Awareness and associate director of operations and scientific outreach at the Broad Institute of MIT and Harvard in Boston.
- Suzie Siegel (@SuzieSiegel), a leiomyosarcoma survivor who served on the Sarcoma Alliance board 2008-2013.
Use the hashtag #scmsm to tweet and find other people’s tweets.